COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 447: Articles 4461-4470  | Next

Counterintuitive effect of antiviral therapy on influenza A-SARS-CoV-2 coinfection due to viral interference
Cheemarla, N. R., Mihaylova, V. T., Watkins, T. A., Foxman, E. F.
10.1101/2023.02.07.527372 — Posted: 2023-02-08
Quantification of impact of COVID-19 pandemic on cancer screening programmes -a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka and Thailand
Lucas, E., Murillo, R., Arrossi, S., Barcena, M., Chami, Y., Nessa, A., Perera, S., Silva, J. P., Sangrajrang, S., Muwonge, R., Basu, P.
10.1101/2023.02.07.23285574 — Posted: 2023-02-08
Patterns of testing in the extensive Danish national SARS-CoV-2 test set-up
Gram, M. A., Steenhard, N., Cohen, A. S., Vangsted, A.-M., Molbak, K., Jensen, T. G., Hansen, C. H., Ethelberg, S.
10.1101/2023.02.06.23285556 — Posted: 2023-02-08
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients
Bodansky, A., Wang, C.-Y., Saxena, A., Mitchell, A., Takahashi, S., Anglin, K., Huang, B., Hoh, R., Lu, S., Goldberg, S. A., Romero, J., Tran, B., Kirtikar, R., Grebe, H., So, M., Greenhouse, B., Durstenfeld, M. S., Hsue, P. Y., Hellmuth, J., Kelly, J. D., Martin, J. N., Anderson, M. S., Deeks, S. G., Henrich, T. J., DeRisi, J. L., Peluso, M. J.
10.1101/2023.02.06.23285532 — Posted: 2023-02-08
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of oral RP7214, a DHODH inhibitor, in Patients with Symptomatic Mild SARS-CoV-2 Infection
Nair, A., Barde, P., Routhu, K. V., Vakkalanka, S., RP7214-2101 Study Group Investigator Authors (India)
10.1101/2023.02.08.23285565 — Posted: 2023-02-08
Mental distress among Norwegian adults during the Covid-19 pandemic: predictors of initial response and subsequent trajectories
Lu, L., Hannigan, L. J., Brandlistuen, R. E., Nesvag, R., Trogstad, L., Magnus, P., Unnarsdottir, A. B., Valdimarsdottir, U. A., Andreassen, O. A., Ask, H.
10.1101/2023.02.06.23285436 — Posted: 2023-02-08
Who Wears the Face Mask? Preventive Measures Against COVID-19 in Latin America Before Vaccination
Renteria, E., Gomez-Casillas, A., Zueras, P.
10.1101/2023.02.07.23285570 — Posted: 2023-02-08
Time series analysis of routine immunisation coverage during the COVID-19 pandemic in 2021 shows continued global decline and increases in Zero Dose children
Evans, B., Keiser, O., Kaiser, L., Jombart, T.
10.1101/2023.02.06.23285411 — Posted: 2023-02-08
Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022
Varkila, M., Montez-Rath, M., Salomon, J., Yu, X., Block, G., Owens, D., Chertow, G., Parsonnet, J., Anand, S.
10.1101/2023.02.06.23285542 — Posted: 2023-02-08
Machine-learning-aided multiplexed nanobiosensor for COVID-19 population immunity profiling
Beisenova, A., Adi, W., Bashar, S. J., Velmurugan, M., Germanson, K. B., Shelef, M. A., Yesilkoy, F.
10.1101/2023.02.06.23285535 — Posted: 2023-02-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).